PROK: ProKidney Corp. Stock

by  •  • Comments Off on PROK: ProKidney Corp. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 103.10
Enterprise Value ($M) 1,400.57
Book Value ($M) 401.64
Book Value / Share 3.10
Price / Book 0.26
NCAV ($M) 356.45
NCAV / Share 2.75
Price / NCAV 0.29

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.17

Liquidity (mrq)
Quick Ratio 10.93
Current Ratio 10.93

Balance Sheet (mrq) ($M)
Current Assets 395.88
Assets 441.07
Liabilities 39.44
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.08
Operating Income -178.35
Net Income -61.19

Cash Flow Statement (mra) ($M)
Cash From Operations -126.35
Cash from Investing 20.41
Cash from Financing 144.41

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-06 13D/A Tolerantia, LLC 38.00 -0.48
11-08 13G/A Morgan Stanley 11.10 29.28
11-08 13G BlackRock, Inc. 5.10 0.00
10-22 13G/A Suvretta Capital Management, Llc 10.47 179.32
06-25 13D/A Control Empresarial de Capitales S.A. de C.V. 25.30 13.37

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 341,946 937,853 36.46
2025-04-16 757,184 2,157,467 35.10
2025-04-15 1,782,317 4,798,232 37.15
2025-04-14 215,803 682,938 31.60

(click for more detail)

Similar Companies
PMCB – PharmaCyte Biotech, Inc. PMN – ProMIS Neurosciences, Inc.
PRFX – PainReform Ltd. PRPH – ProPhase Labs, Inc.
PRQR – ProQR Therapeutics N.V.


Financial data and stock pages provided by
Fintel.io